Cargando…

6-OHDA-induced dopaminergic neurodegeneration in Caenorhabditis elegans is promoted by the engulfment pathway and inhibited by the transthyretin-related protein TTR-33

Oxidative stress is linked to many pathological conditions including the loss of dopaminergic neurons in Parkinson’s disease. The vast majority of disease cases appear to be caused by a combination of genetic mutations and environmental factors. We screened for genes protecting Caenorhabditis elegan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Offenburger, Sarah-Lena, Ho, Xue Yan, Tachie-Menson, Theresa, Coakley, Sean, Hilliard, Massimo A., Gartner, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773127/ https://www.ncbi.nlm.nih.gov/pubmed/29346382 http://dx.doi.org/10.1371/journal.pgen.1007125

Ejemplares similares

Mutations in Caenorhabditis elegans neuroligin-like glit-1, the apoptosis pathway and the calcium chaperone crt-1 increase dopaminergic neurodegeneration after 6-OHDA treatment
por: Offenburger, Sarah-Lena, et al.
Publicado: (2018)

Tetraspanin (TSP-17) Protects Dopaminergic Neurons against 6-OHDA-Induced Neurodegeneration in C. elegans
por: Masoudi, Neda, et al.
Publicado: (2014)

Chronic high-sugar diet in adulthood protects Caenorhabditis elegans from 6-OHDA-induced dopaminergic neurodegeneration
por: Morton, Katherine S., et al.
Publicado: (2023)

Exposure to Mitochondrial Genotoxins and Dopaminergic Neurodegeneration in Caenorhabditis elegans
por: González-Hunt, Claudia P., et al.
Publicado: (2014)

Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans
por: Cheon, Se-Myeong, et al.
Publicado: (2016)

Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
por: Benson, Merrill D, et al.
Publicado: (2015)

Abl Kinase Inhibits the Engulfment of Apopotic Cells in Caenorhabditis elegans
por: Hurwitz, Michael E, et al.
Publicado: (2009)

Morphological hallmarks of dopaminergic neurodegeneration are associated with altered neuron function in Caenorhabditis elegans
por: Clark, Andrew S., et al.
Publicado: (2023)

Correction: Abl Kinase Inhibits the Engulfment of Apopotic Cells in Caenorhabditis elegans
por: Hurwitz, Michael E, et al.
Publicado: (2009)

Caenorhabditis elegans Myotubularin MTM-1 Negatively Regulates the Engulfment of Apoptotic Cells
por: Zou, Wei, et al.
Publicado: (2009)

Necrotic Neurodegeneration in Caenorhabditis Elegans
por: Xu, Keli, et al.
Publicado: (2001)

Modeling neurodegeneration in Caenorhabditis elegans
por: Caldwell, Kim A., et al.
Publicado: (2020)

Downregulation of eEF1A/EFT3-4 Enhances Dopaminergic Neurodegeneration After 6-OHDA Exposure in C. elegans Model
por: Chalorak, Pawanrat, et al.
Publicado: (2020)

C. elegans transthyretin-like protein TTR-52 mediates recognition of apoptotic cells by the CED-1 phagocyte receptor
por: Wang, Xiaochen, et al.
Publicado: (2010)

Transthyretin familial amyloid polyneuropathy (TTR‐FAP): Parameters for early diagnosis
por: Escolano‐Lozano, Fabiola, et al.
Publicado: (2017)

Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson’s Disease
por: Zhang, Siyan, et al.
Publicado: (2020)

Comparative genetic, proteomic and phosphoproteomic analysis of C. elegans embryos with a focus on ham-1/STOX and pig-1/MELK in dopaminergic neuron development
por: Offenburger, Sarah-Lena, et al.
Publicado: (2017)

A dominant mutation in mec-7/β-tubulin affects axon development and regeneration in Caenorhabditis elegans neurons
por: Kirszenblat, Leonie, et al.
Publicado: (2013)

Mechanistic impacts of bacterial diet on dopaminergic neurodegeneration in a Caenorhabditis elegans α-synuclein model of Parkinson’s disease
por: Gaeta, Anthony L., et al.
Publicado: (2023)

Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD
por: Rios, Xabier, et al.
Publicado: (2019)

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa
por: Jacobson, Daniel R., et al.
Publicado: (2016)

The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis
por: Bemporad, Francesco, et al.
Publicado: (2022)

Santalol Isomers Inhibit Transthyretin Amyloidogenesis and Associated Pathologies in Caenorhabditis elegans
por: Mohankumar, Amirthalingam, et al.
Publicado: (2022)

Uptake of Aggregating Transthyretin by Fat Body in a Drosophila Model for TTR-Associated Amyloidosis
por: Pokrzywa, Malgorzata, et al.
Publicado: (2010)

Mild pentachlorophenol-mediated uncoupling of mitochondria depletes ATP but does not cause an oxidized redox state or dopaminergic neurodegeneration in Caenorhabditis elegans
por: Markovich, Zachary R., et al.
Publicado: (2022)

An unbiased, automated platform for scoring dopaminergic neurodegeneration in C. elegans
por: Clark, Andrew S., et al.
Publicado: (2023)

An unbiased, automated platform for scoring dopaminergic neurodegeneration in C. elegans
por: Clark, Andrew S., et al.
Publicado: (2023)

Neuroprotection of Anakinra on peripheral nerve neurodegeneration in single and combination protocols with TTR siRNA in a transgenic mouse model for human V30M transthyretin
por: Saraiva, Maria João, et al.
Publicado: (2015)

A phase 3 clinical trial with ISIS-TTRRx, a 2nd-generation antisense oligonucleotide targeting transthyretin (TTR), for the treatment of TTR amyloid cardiomyopathy
por: Millns, Helen, et al.
Publicado: (2015)

Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy “in disguise”
por: Grandis, Marina, et al.
Publicado: (2018)

Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis
por: Eze, Fredrick Nwude, et al.
Publicado: (2019)

Caenorhabditis elegans as a model system to study post-translational modifications of human transthyretin
por: Henze, Andrea, et al.
Publicado: (2016)

Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening
por: Tsuda, Yukimoto, et al.
Publicado: (2018)

Functional Modulators of Resilience to Age-Associated Dopaminergic Neurodegeneration in C. elegans
por: Caldwell, Guy
Publicado: (2020)

Role of Presenilin in Mitochondrial Oxidative Stress and Neurodegeneration in Caenorhabditis elegans
por: Sarasija, Shaarika, et al.
Publicado: (2018)

Flavonoids mitigate neurodegeneration in aged Caenorhabditis elegans by mitochondrial uncoupling
por: Cho, Injeong, et al.
Publicado: (2020)

Diflunisal compassive use in transthyretin familial amyloidotic polyneuropathy (TTR-FAP): report of the first Spanish experience
por: Contesse, Sebastián E Azorín, et al.
Publicado: (2015)

In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS)
por: Dharpure, Rupal, et al.
Publicado: (2022)

Studies on the Requirement of Transthyretin Protein (BxTTR-52) for the Suppression of Host Innate Immunity in Bursaphelenchus xylophilus
por: Wen, Tong-Yue, et al.
Publicado: (2022)

Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP
por: Parman, Yesim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bb659a51li4o34gd19cup320el